Yongye Biotechnology International Announces Second Quart... ( BEIJING Aug. 18 /Xinhua-- Yongye ...)

Yongye Biotechnology International Announces Second Quarter Results

Date:8/18/2008

BEIJING, Aug. 18 /Xinhua-PRNewswire-FirstCall/ -- Yongye Biotechnology International, Inc. (OTC Bulletin Board: YGYB) ("Yongye" or the "Company"), a leading developer, producer and distributor of nutrients for plants and animals in the People's Republic of China, today announced its financial results for the quarter ended June 30, 2008.

Second Quarter 2008 Highlights

-- Revenue was $17.6 million, an increase of 136.6% from the second

quarter of 2007, and an increase of 87.0% from the first quarter of

2008

-- Gross profit was $9.6 million, a 171.8% increase from the second

quarter of 2007, with a gross margin of 54.5%

-- Net income was $7.2 million, an increase of 116.2% from the second

quarter of 2007, or $0.41 per diluted share

-- Completed a share exchange transaction to become a publicly traded

company in April 2008

-- Raised $10.0 million gross proceeds through a private placement

financing in April 2008

Second Quarter 2008 Financial Results

"The second quarter of the year is typically our strongest quarter for sales of plant and animal nutrient products, and this year's second quarter had exceptionally good results, with both revenue and earnings more than doubling from the prior year period," said Mr. Zishen Wu, Chief Executive Officer of Yongye. "We attribute this to the very strong benefits our customers are able to gain from the use of our technologically advanced products and the rapid expansion of our distribution network to cover new geographic regions and build strong brand recognition for our products."

Second Quarter 2008 Results

Revenue was $17.6 million in the second quarter of 2008, an increase of 136.6% from $7.4 million in the second quarter of 2007. This significant revenue increase was due mainly to the rapid expansion of the Company's sales network. An additional 425 branded stores were added to the distribution n
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11
Related biology technology :

1. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
2. Yongye Biotechnology International Retains CCG Investor Relations
3. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
4. Yongye Biotechnology Completes Reverse Merger and Completes $10.0 Million Private Financing
5. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
6. New Book on the Business of Biotechnology
7. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
8. Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results
9. Athera Biotechnology Founder Johan Frostegard and His Colleagues Win NACB Distinguished Abstract Award at AACC 2008
10. Pennsylvania Governor Rendell Says State Number 1 in New Biotechnology Study
11. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology

Post Your Comments:

(Date:6/19/2013)... 2013 A new look at “big ... other trends will highlight technical sessions at SPIE ... In its 33rd year, the three-day event is the ... key suppliers, approximately 100 technical presentations and numerous networking ... society for optics and photonics , the meeting will ...

(Date:6/18/2013)... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing, and stem ... results for the fourth quarter and full year of ... Fourth Quarter of Fiscal 2013 Highlights , ... by 33.3% to RMB133.0 million ($21.4 million) from RMB99.8 ...

(Date:6/18/2013)... Miami, FL (PRWEB) June 18, 2013 The ... associate the skin as an important human body part. Similar ... cared for in order to function, repair and grow. Recent ... with vitamins and supplements, is just as important as other ... and supplements to aid in skin cell reproduction, increase the ...

(Date:6/18/2013)... June 18, 2013 regulated information — Global biopharmaceutical ... today announced the launch of a new Pledge ... The Pledge empowers the millions ... and make a personal commitment to demand more: greater ... care team and additional partial-onset seizure control. More information ...

[0] ‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology [0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin [0] Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy

... Jan. 6, 2011 Amgen (Nasdaq: AMGN ... collaborate to develop XmAb ® 5871, an Fc- engineered ... currently in late-stage preclinical development for the treatment of ... the agreement, Amgen has the option to an exclusive ...

... (Nasdaq: NEOG ) announced today that it has ... to replace the retiring Richard Current. Current will immediately relinquish ... the end of the fiscal year, May 31. ... last eight as CFO, vice president of finance, and treasurer. ...

... Verenium Corporation (Nasdaq: VRNM ), a pioneer ... solutions, today announced that the lawsuit filed ... dismissed. Verenium,s motion for summary judgment to dismiss CVI,s ... for the Southern District of New York. CVI,s complaint ...

Cached Biology Technology:Amgen and Xencor Enter Option Deal to Co-Develop Xencor's Novel Antibody for Autoimmune Diseases 2 Amgen and Xencor Enter Option Deal to Co-Develop Xencor's Novel Antibody for Autoimmune Diseases 3 Neogen Names Quinlan as CFO 2 Verenium Announces Favorable Outcome of Capital Ventures International Lawsuit 2 Verenium Announces Favorable Outcome of Capital Ventures International Lawsuit 3

Amgen and Xencor Enter Option Deal to Co-Develop Xencor's Novel Antibody for Autoimmune Diseases Neogen Names Quinlan as CFO Verenium Announces Favorable Outcome of Capital Ventures International Lawsuit

(Date:6/18/2013)... D.C. June 18, 2013 Joshua Obar, Ph.D., ... has been honored with a 2013 ICAAC Young Investigator ... regulation of immunological memory responses to infection. , ... University in 2001 and went on to complete his ... 2006. He performed his Ph.D. thesis research in ...

(Date:6/18/2013)... to a chemical modification of DNA and this ... the DNA sequence. Until now, scientists believed that ... certain genes. Today, a team of researchers from ... Emmanouil Dermitzakis, Louis-Jeantet Professor at the Faculty of ... case and that DNA methylation may play both ...

(Date:6/17/2013)... locations with central nervous system infections may well be ... according to a study to be published in ... Society for Microbiology. Researchers have detected the virus in ... central nervous system infections of unknown cause, and in ... pigs and poultry, suggesting animals may serve as reservoirs ...

Breaking Biology News(10 mins):The American Society for Microbiology honors Joshua Obar 2 The secret of DNA methylation 2 New virus discovered in patients with central nervous system infections 2 New virus discovered in patients with central nervous system infections 3

[0] The American Society for Microbiology honors Joshua Obar [0] The secret of DNA methylation [0] New virus discovered in patients with central nervous system infections

... Recognized by ... the Leading Guide for Office Equipment ... of,America, Inc., a market leader in document imaging scanners ... "Editor,s Choice",designation in the Better Buys for Business 2008 ...

... discovered that a gene controlling whether blood vessels differentiate ... to a vascular disorder in the brain that causes ... and the new findings are the first to provide ... particular brain disorder, known as BAVM, and to provide ...

... NY, Sept. 2, 2008) People concerned about the ... families and communities will have a unique opportunity to ... about the causes, symptoms and progression of such illnesses ... learn about current and potential treatments. In an ...

Cached Biology News:Fujitsu Scanners Selected as 'Editor's Choice' in Better Buys for Business 2008 Scan-to-File Guide 2 Fujitsu Scanners Selected as 'Editor's Choice' in Better Buys for Business 2008 Scan-to-File Guide 3 Gene is likely cause of stroke-inducing vascular malformations 2 Gene is likely cause of stroke-inducing vascular malformations 3 Healthy Minds Across America features 48 public forums on mental health research, Sept. 14 2 Healthy Minds Across America features 48 public forums on mental health research, Sept. 14 3

Fujitsu Scanners Selected as 'Editor's Choice' in Better Buys for Business 2008 Scan-to-File Guide Gene is likely cause of stroke-inducing vascular malformations Healthy Minds Across America features 48 public forums on mental health research, Sept. 14

... Protein DetectorTM Microarray Dot Blot Kits overcome ... and quantitation over a wide range in ... ) detection. They are ideal for ... hundreds of samples for the presence of ...

... Convenient, easy-to-use kits for arraying ... detection using common lab equipment. DiscoverLight ... analysis of your protein, cell lysate ... format. The kits include specially designed ...

Request Info...

... StabilZyme AP Conjugate Stabilizer is ... purified bovine protein and other non-toxic ... (4-Morpholine-ethanesulfonic acid), pH 5.5 6.5. ... of 0.02% methylisothiazolone and 0.02% bromonitrodioxane ...

Biology Products:

Protein Detector Microarray Dot Blot Kit, AP Chemiluminescent from KPL DISCOVERLIGHT RABBIT ARRA from Pierce Biotechnology, Inc.Conjugate Stabilizing Diluent Alkaline Phosphatase from Meridian Life Science, Inc.StabilZyme AP Conjugate Stabilizer from SurModics, Inc.